SEC Form 4 · accession 0001547522-17-000040
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Scott Tomsche
Director
Period of report
Mar 13, 2017
Accepted (ET)
Mar 15, 2017 · 2:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per share | Mar 13, 2017 | P | 490 | $5.40 | A | 71,279 | D | |
| Common Stock, par value $0.10 per share | Mar 13, 2017 | P | 313 | $5.45 | A | 71,592 | D | |
| Common Stock, par value $0.10 per share | Mar 14, 2017 | P | 150 | $5.46 | A | 71,742 | D | |
| Common Stock, par value $0.10 per share | Mar 14, 2017 | P | 658 | $5.45 | A | 72,400 | D | |
| Common Stock, par value $0.10 per shareF1 | Mar 14, 2017 | P | 389 | $5.41 | A | 72,789 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1(1) This figure includes 2,322 shares of common stock held by immediate family members of Dr. Tomsche.